Malignant neoplasm of prostate (controls excluding all cancers)

C3_PROSTATE_EXALLC

No definition available.

Endpoint definition

↥

FinnGen phenotype data

individuals

diagram downward connector

Apply sex-specific rule

Sex only males

diagram downward connector

Check conditions None

diagram downward connector

Check pre-conditions, main-only, mode, registry filters

Cause of death: ICD-10 C61

Cause of death: ICD-9 185

Cause of death: ICD-8 185

KELA reimbursements: KELA codes 116

Cancer registry: Topography ICD-O-3 C61

Cancer registry: Morphology ICD-O-3 ANY

Cancer registry: Behaviour codes 3

3 out of 7 registries used, show all original rules.

-

diagram downward connector

Check minimum number of events None

-

diagram downward connector

Include endpoints None

-

diagram downward connector

diagram downward connector

Remove individuals based on genotype QC

13216

diagram downward connector

C3_PROSTATE_EXALLC

Control definitions

Control exclude C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF9

NAME	C3_PROSTATE_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	1
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C61
COD_ICD_9	185
COD_ICD_8	185
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB	116
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C61
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Show upset plot detailing case counts by codes

Or the full data table

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of prostate (controls excluding all cancers) based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Malignant neoplasm of prostate

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	13216	-	13216
Unadjusted prevalence (%)	3.50	-	7.95
Mean age at first event (years)	68.82	-	68.82

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.05	2.67 [2.16, 3.30]	5.2e-20	3365
15 years	0.01	1.61 [1.38, 1.86]	4.8e-10	1533
5 years	0.00	3.20 [2.86, 3.57]	1.5e-94	1150
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: C3_PROSTATE_EXALLC – Malignant neoplasm of prostate (controls excluding all cancers)
GWS hits: 76

Survival analyses between endpoints

↥

Plot

before Malignant neoplasm of prostate (controls excluding all cancers)
after Malignant neoplasm of prostate (controls excluding all cancers)

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Malignant neoplasm of prostate (controls excluding all cancers)

↥

Endpoint not on priority list, no data to show.